Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 27
1946 80
1947 97
1948 101
1949 135
1950 84
1951 96
1952 99
1953 105
1954 109
1955 110
1956 141
1957 162
1958 150
1959 171
1960 210
1961 203
1962 181
1963 120
1964 119
1965 55
1966 2
1968 1
1969 1
1970 3
1972 2
1973 2
1974 4
1975 10
1976 1
1977 6
1978 13
1979 14
1980 29
1981 48
1982 31
1983 41
1984 64
1985 59
1986 61
1987 50
1988 63
1989 48
1990 63
1991 71
1992 92
1993 81
1994 79
1995 105
1996 84
1997 117
1998 197
1999 277
2000 357
2001 830
2002 837
2003 845
2004 1078
2005 1318
2006 1321
2007 1489
2008 1617
2009 1526
2010 1573
2011 1517
2012 1434
2013 1385
2014 1347
2015 1174
2016 980
2017 927
2018 942
2019 962
2020 829
2021 613
2022 684
2023 594
2024 685
2025 404

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28,268 results

Results by year

Filters applied: . Clear all
Page 1
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis.
Richeldi L, Azuma A, Cottin V, Kreuter M, Maher TM, Martinez FJ, Oldham JM, Valenzuela C, Clerisme-Beaty E, Gordat M, Wachtlin D, Liu Y, Schlecker C, Stowasser S, Zoz DF, Wijsenbeek MS; FIBRONEER-IPF Trial Investigators. Richeldi L, et al. N Engl J Med. 2025 Jun 12;392(22):2193-2202. doi: 10.1056/NEJMoa2414108. Epub 2025 May 18. N Engl J Med. 2025. PMID: 40387033 Clinical Trial.
Nerandomilast in Patients with Progressive Pulmonary Fibrosis.
Maher TM, Assassi S, Azuma A, Cottin V, Hoffmann-Vold AM, Kreuter M, Oldham JM, Richeldi L, Valenzuela C, Wijsenbeek MS, Clerisme-Beaty E, Coeck C, Gu H, Ritter I, Schlosser A, Stowasser S, Voss F, Weimann G, Zoz DF, Martinez FJ; FIBRONEER-ILD Trial Investigators. Maher TM, et al. N Engl J Med. 2025 Jun 12;392(22):2203-2214. doi: 10.1056/NEJMoa2503643. Epub 2025 May 19. N Engl J Med. 2025. PMID: 40388329 Clinical Trial.
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.
Khanani AM, Patel SS, Staurenghi G, Tadayoni R, Danzig CJ, Eichenbaum DA, Hsu J, Wykoff CC, Heier JS, Lally DR, Monés J, Nielsen JS, Sheth VS, Kaiser PK, Clark J, Zhu L, Patel H, Tang J, Desai D, Jaffe GJ; GATHER2 trial investigators. Khanani AM, et al. Lancet. 2023 Oct 21;402(10411):1449-1458. doi: 10.1016/S0140-6736(23)01583-0. Epub 2023 Sep 8. Lancet. 2023. PMID: 37696275
Synthetic Organic Electrochemistry: Calling All Engineers.
Yan M, Kawamata Y, Baran PS. Yan M, et al. Angew Chem Int Ed Engl. 2018 Apr 9;57(16):4149-4155. doi: 10.1002/anie.201707584. Epub 2017 Nov 3. Angew Chem Int Ed Engl. 2018. PMID: 28834012 Free PMC article. Review.
28,268 results
You have reached the last available page of results. Please see the User Guide for more information.